Earnings History Data for Axsome Therapeutics, Inc. (AXSM) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing novel therapies for the management of pain and other central nervous system disorders. Its product candidate portfolio consists of AXS-02 and AXS-05 which are in clinical trial stage. Axsome Therapeutics, Inc. is based in New York.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
05-08-2024 PM AXSM Axsome Therapeutics, Inc. 4,090 -1.24 -1.30 1.00 Axsome Therapeutics GAAP EPS of -$1.67 misses by $0.34, revenue of $87.2M beats by $0.27M
[8/5/2024 7:01 AM]
83.18 -1.24 
(-1.47%)
75.01 -9.41 
(-11.15%)
55.02 - 98.40 766,594 530,000 4,233
06-05-2024 PM AXSM Axsome Therapeutics, Inc. 3,510 -1.09 -1.20 -0.22 Axsome Therapeutics GAAP EPS of -$1.44 misses by $0.21, revenue of $75M beats by $2.15M
[5/6/2024 7:01 AM]
75.86 1.06 
(1.42%)
74.75 -0.05 
(-0.07%)
55.02 - 98.40 726,095 500,000 5,712
20-02-2024 PM AXSM Axsome Therapeutics, Inc. 4,420 -0.73 -1.21 -1.28 Axsome Therapeutics GAAP EPS of -$2.08 misses by $0.92, revenue of $71.53M beats by $2.49M
[2/20/2024 7:10 AM]
81.42 -11.39 
(-12.28%)
85.40 -7.41 
(-7.98%)
53.71 - 98.40 2,824,374 560,000 28,315
06-11-2023 PM AXSM Axsome Therapeutics, Inc. 3,040 -1.32 -1.24 -1.03 Axsome Therapeutics GAAP EPS of -$1.32 misses by $0.09, revenue of $57.79M beats by $2.93M
[11/6/2023 7:02 AM]
62.50 -2.64 
(-4.05%)
62.42 -0.08 
(-0.13%)
49.60 - 91.29 1,211,820 680,000 2,522
07-08-2023 PM AXSM Axsome Therapeutics, Inc. 3,280 -1.00 -1.24 -1.06 Axsome Therapeutics GAAP EPS of -$1.54 misses by $0.30, revenue of $46.01M beats by $5.06M
[8/7/2023 7:01 AM]
71.09 -2.57 
(-3.49%)
75.25 1.59 
(2.16%)
38.87 - 91.29 1,754,395 750,000 55,908
08-05-2023 PM 7:00 AM ET
(May 8)
AXSM Axsome Therapeutics, Inc. 3,100 -0.22 -1.13 -1.03 Axsome TherapeuticsEPS of -$0.26, revenue of $94.6M beats by $69.12M
[5/8/2023 7:03 AM]
77.20 3.46 
(4.69%)
77.65 3.91 
(5.30%)
20.63 - 82.85 2,626,732 570,000 58,020
27-02-2023 PM 7:00 AM ET
(Feb 27)
AXSM Axsome Therapeutics, Inc. 2,720 -1.28 -1.18 -0.90 Axsome Therapeutics GAAP EPS of -$1.41 misses by $0.28, revenue of $24.37M beats by $2.49M
[2/27/2023 7:02 AM]
64.06 3.02 
(4.94%)
63.80 2.75 
(4.50%)
20.63 - 82.00 1,468,166 930,000 42,181
07-11-2022 PM 7:00 AM ET
(Nov 7)
AXSM Axsome Therapeutics, Inc. 2,590 -1.03 -1.10 -0.93 Axsome Therapeutics GAAP EPS of -$1.07 beats by $0.02, revenue of $16.8M misses by $0.26M
[11/7/2022 7:03 AM]
56.76 -0.33 
(-0.58%)
54.53 -2.56 
(-4.48%)
20.63 - 71.98 1,022,832 1,530,000 23,010
09-08-2022 PM 7:05 AM ET
(Aug 9)
AXSM Axsome Therapeutics, Inc. 1,570 -1.06 -1.19 -0.86 Axsome Therapeutics GAAP EPS of -$1.06 beats by $0.18, revenue of $8.81M beats by $2.52M
[8/9/2022 7:03 AM]
44.98 1.67 
(3.86%)
40.20 -3.11 
(-7.18%)
19.38 - 47.49 1,473,885 710,000 53,317
02-05-2022 PM 7:00 AM ET
(May 2)
AXSM Axsome Therapeutics, Inc. 1,250 -1.03 -1.02 -0.78 Axsome Therapeutics GAAP EPS of -$1.03 misses by $0.03
[5/2/2022 7:09 AM]
34.09 2.34 
(7.38%)
31.59 -0.16 
(-0.50%)
19.38 - 74.10 1,129,801 2,420,000 81,599
01-03-2022 PM 7:00 AM ET
(Mar 1)
AXSM Axsome Therapeutics, Inc. 1,060 -0.90 -0.99 -0.78 Axsome Therapeutics GAAP EPS of -$0.90 beats by $0.08
[3/1/2022 7:03 AM]
30.85 2.74 
(9.75%)
28.24 0.13 
(0.46%)
19.38 - 74.10 1,315,397 620,000 93,587
08-11-2021 PM 7:05 AM ET
(Nov 8)
AXSM Axsome Therapeutics, Inc. 1,540 -0.93 -0.94 -0.58 Axsome Therapeutics EPS beats by $0.03
[11/8/2021 7:03 AM]
43.35 3.15 
(7.84%)
39.27 -0.93 
(-2.31%)
19.38 - 87.24 1,558,082 620,000 153,436
09-08-2021 PM 7:00 AM ET
(Aug 9)
AXSM Axsome Therapeutics, Inc. 1,830 -0.86 -0.88 -0.49 Axsome Therapeutics EPS beats by $0.07
[8/9/2021 7:05 AM]
27.36 -23.80 
(-46.52%)
33.10 -18.06 
(-35.30%)
27.30 - 90.00 9,128,010 340,000 1,558,545
10-05-2021 PM 7:00 AM ET
(May 10)
AXSM Axsome Therapeutics, Inc. 2,310 -0.78 -0.83 -0.88 Axsome Therapeutics EPS beats by $0.04
[5/10/2021 7:05 AM]
54.04 -2.92 
(-5.13%)
58.64 1.68 
(2.95%)
50.05 - 94.06 320,297 590,000 644
01-03-2021 PM 7:00 AM ET
(Mar 1)
AXSM Axsome Therapeutics, Inc. 2,700 -0.78 -0.73 -0.71 Axsome Therapeutics EPS misses by $0.08
[3/1/2021 7:02 AM]
69.09 1.73 
(2.57%)
67.36 0.0 
(0.00%)
35.44 - 109.53 415,318 293,066 8,519
05-11-2020 PM 7:05 AM ET
(Nov 5)
AXSM Axsome Therapeutics, Inc. 2,590 -0.58 -0.58 -0.56 Axsome Therapeutics EPS misses by $0.03
[11/5/2020 7:18 AM]
69.51 -5.22 
(-6.99%)
69.51 0.0 
(0.00%)
20.48 - 109.94 569,460 271,759 3,154
10-08-2020 PM 7:00 AM ET
(Aug 10)
AXSM Axsome Therapeutics, Inc. 2,890 -0.49 -0.54 -0.41 Axsome Therapeutics EPS beats by $0.12
[8/10/2020 7:08 AM]
82.11 4.04 
(5.17%)
80.96 2.89 
(3.70%)
13.64 - 109.94 277,507 373,825 3,162